JENNIFER GORDON: Open Payments
NPI 1235511072 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 10 payments from 6 companies in 2025. Trend: 2023 $728 · 2024 $699 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $249 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| Mallinckrodt Hospital Products Inc. | 1 | $36 |
| Soleno Therapeutics, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $14 |
Products named: FANAPT, UZEDY, ACTHAR, VYKAT XR, INGREZZA, HETLIOZ, VRAYLAR.
Industry payments across KY — which companies pay providers there.
